Wikipedia -WSS

Wikipedia

author：focus 2025-10-02 08:21:30 - browse：3

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Change Healthcare outage fallout shows need for new oversight

WSS

Medicare coverage of Wegovy, once blocked, now looks possible

Maui funeral service workers on devastation of fires: 'I'm in shock'

Male and female sex labels in research insufficient, scientists say

CDC overhauls leadership of center that led response to Covid

Newly revealed memo details efforts to keep Trump in power following election loss

Faced with fears of OxyContin misuse, sales reps touted its safety

Wikipedia

Wikipedia

knowledge

How one medical school became remarkably diverse

Why depression after traumatic brain injury is distinct

Peter Hotez and the public health issue of online harassment

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Bright Health sells Medicare Advantage business to Molina

Where are patients getting their prescriptions for GLP

Virginia high school admissions case could be legal follow

John Green on his newest strategy for fighting tuberculosis

Heart attack and stroke risk calculators need revising

WuXi out of biotech trade group, U.S. and China relations to blame

Wikipedia

CDC overhauls leadership of center that led response to Covid

RaDonda Vaught links Vanderbilt hospital issues to patient death

Faced with fears of OxyContin misuse, sales reps touted its safety

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

First U.S. drug developed to treat liver disease MASH is approved

Genentech weighs delaying cancer therapy after drug pricing law

entertainment

knowledge

hotspot

entertainment